Skip to main content
Top
Published in:

Open Access 01-12-2024 | Research

Revealing disparities in representation in knowledge generation and guideline development

Authors: Carlos P. B. Almeida, Afom T. Andom, Alain Casseus, Jacquelyn-My Do, Alain Gelin, Leonid Lecca, Maxo Luma, Michael Mazzi, Carole D. Mitnick, Jean Claude Mugunga, Melino Ndayizigiye, Natalie Nguyen, Meseret Tamirat, Girum Tefera, Sterman Toussaint, Marco Tovar, Christine Tzelios

Published in: BMC Health Services Research | Issue 1/2024

Login to get access

Abstract

Background

Multidrug-resistant tuberculosis (MDR/RR-TB) is a major global health challenge, disproportionately affecting low- and lower-middle-income countries (LLMICs). The World Health Organization (WHO) generates guidance to address the problem. Here, we explore the extent to which guidance and related knowledge are generated by experts living in the most-affected countries and consider the results in the context of the movement to decolonize global health.

Methods

We examined the composition of World Health Organization (WHO) MDR/RR-TB treatment Guideline Development Groups (GDGs) from 2016 to 2022. We classified GDG members according to the MDR/RR-TB burden and World Bank income level of the country of their institutional affiliation. We also searched PubMed to identify peer-reviewed publications from 2016 to 2023 which emanated from individual-patient-data meta-analysis like those done for Guideline review, and classified the publication authors according to the same indicators.

Results

There were 33 high-burden MDR/RR-TB countries during the time period. Of these, 72.1% were LLMICs and none was high-income. In contrast, only 30.3% of WHO GDG members and 10.4% of peer-reviewed publication authors were from LLMICs. Representatives from high-MDR/RR-TB-burden countries comprised 34.3% of WHO GDG members and 14.7% of authors of guideline-related publications.

Conclusions

The important imbalance between the geographical distribution of lived experience with MDR/RR-TB and the distribution of individuals generating knowledge and guidance on treatment of MDR/RR-TB can have clinical and resource implications. Countries may reject or defer guideline adoption because of a mismatch between that guidance and local disease epidemiology. Funding conditioned on compliance with guidelines can exacerbate health inequalities. The movement to decolonize global health considers representation disparities as epistemic injustice, that is unfair treatment in the process of generating, sharing, or receiving knowledge. Reform is possible in many of the institutions involved in generation of global health knowledge, such as: meaningful participation of LLMICs in projects as a requirement for research funding, improved attention to the epistemic and geographical location of journal editorial staff, and broader inclusion in guidelines committees. Better alignment of participation in knowledge generation with burden of disease holds potential for reducing inequality and improving relevance of guidance for the lived experience with MDR/RR-TB.
Appendix
Available only for authorised users
Literature
2.
go back to reference World Health Organization. WHO consolidated guidelines on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment, 2022 update. Geneva: World Health Organization; 2022. World Health Organization. WHO consolidated guidelines on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment, 2022 update. Geneva: World Health Organization; 2022.
3.
go back to reference World Health Organization. WHO consolidated guidelines on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment. Geneva: World Health Organization; 2020. World Health Organization. WHO consolidated guidelines on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment. Geneva: World Health Organization; 2020.
4.
go back to reference World Health Organization. WHO consolidated guidelines on drug-resistant tuberculosis treatment. Geneva: World Health Organization; 2019. World Health Organization. WHO consolidated guidelines on drug-resistant tuberculosis treatment. Geneva: World Health Organization; 2019.
5.
go back to reference World Health Organization. WHO treatment guidelines for drug-resistant tuberculosis, 2016 update. Geneva: World Health Organization; 2016. World Health Organization. WHO treatment guidelines for drug-resistant tuberculosis, 2016 update. Geneva: World Health Organization; 2016.
6.
go back to reference Saluja K, Reddy KS, Wang Q, Zhu Y, Li Y, Chu X, et al. Improving WHO’s understanding of WHO guideline uptake and use in Member States: a scoping review. Health Res Policy Syst. 2022;20(1):98.CrossRefPubMedPubMedCentral Saluja K, Reddy KS, Wang Q, Zhu Y, Li Y, Chu X, et al. Improving WHO’s understanding of WHO guideline uptake and use in Member States: a scoping review. Health Res Policy Syst. 2022;20(1):98.CrossRefPubMedPubMedCentral
7.
go back to reference Olayemi E, Asare EV, Benneh-Akwasi Kuma AA. Guidelines in lower-middle income countries. Br J Haematol. 2017;177(6):846–54.CrossRefPubMed Olayemi E, Asare EV, Benneh-Akwasi Kuma AA. Guidelines in lower-middle income countries. Br J Haematol. 2017;177(6):846–54.CrossRefPubMed
8.
go back to reference Nasser SM, Cooke G, Kranzer K, Norris SL, Olliaro P, Ford N. Strength of recommendations in WHO guidelines using GRADE was associated with uptake in national policy. J Clin Epidemiol. 2015;68(6):703–7.CrossRefPubMed Nasser SM, Cooke G, Kranzer K, Norris SL, Olliaro P, Ford N. Strength of recommendations in WHO guidelines using GRADE was associated with uptake in national policy. J Clin Epidemiol. 2015;68(6):703–7.CrossRefPubMed
9.
go back to reference Silver JK. Is a lack of diversity among clinical practice guideline authors contributing to health inequalities for patients? BMJ. 2023;381:p1035.CrossRef Silver JK. Is a lack of diversity among clinical practice guideline authors contributing to health inequalities for patients? BMJ. 2023;381:p1035.CrossRef
12.
go back to reference Kelaher M, Ng L, Knight K, Rahadi A. Equity in global health research in the new millennium: trends in first-authorship for randomized controlled trials among low- and middle-income country researchers 1990–2013. Int J Epidemiol. 2017;45(6):2174–83.CrossRef Kelaher M, Ng L, Knight K, Rahadi A. Equity in global health research in the new millennium: trends in first-authorship for randomized controlled trials among low- and middle-income country researchers 1990–2013. Int J Epidemiol. 2017;45(6):2174–83.CrossRef
13.
go back to reference Mbaye R, Gebeyehu R, Hossmann S, Mbarga N, Bih-Neh E, Eteki L, et al. Who is telling the story? A systematic review of authorship for infectious disease research conducted in Africa, 1980–2016. BMJ Glob Health. 2019;4(5):e001855.CrossRefPubMedPubMedCentral Mbaye R, Gebeyehu R, Hossmann S, Mbarga N, Bih-Neh E, Eteki L, et al. Who is telling the story? A systematic review of authorship for infectious disease research conducted in Africa, 1980–2016. BMJ Glob Health. 2019;4(5):e001855.CrossRefPubMedPubMedCentral
14.
go back to reference Charani E, Abimbola S, Pai M, Adeyi O, Mendelson M, Laxminarayan R, et al. Funders: the missing link in equitable global health research? PLOS Glob Public Health. 2022;2(6):e0000583.CrossRefPubMedPubMedCentral Charani E, Abimbola S, Pai M, Adeyi O, Mendelson M, Laxminarayan R, et al. Funders: the missing link in equitable global health research? PLOS Glob Public Health. 2022;2(6):e0000583.CrossRefPubMedPubMedCentral
16.
go back to reference Morgan R, Lundine J, Irwin B, Grepin KA. Gendered geography: an analysis of authors in The Lancet Global Health. Lancet Glob Health. 2019;7(12):e1619–20.CrossRefPubMed Morgan R, Lundine J, Irwin B, Grepin KA. Gendered geography: an analysis of authors in The Lancet Global Health. Lancet Glob Health. 2019;7(12):e1619–20.CrossRefPubMed
20.
go back to reference Andrews JC, Schunemann HJ, Oxman AD, Pottie K, Meerpohl JJ, Coello PA, et al. GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation’s direction and strength. J Clin Epidemiol. 2013;66(7):726–35.CrossRefPubMed Andrews JC, Schunemann HJ, Oxman AD, Pottie K, Meerpohl JJ, Coello PA, et al. GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation’s direction and strength. J Clin Epidemiol. 2013;66(7):726–35.CrossRefPubMed
22.
go back to reference van Dijk WB, Schuit E, van der Graaf R, Groenwold RHH, Laurijssen S, Casadei B, et al. Applicability of European Society of Cardiology guidelines according to gross national income. Eur Heart J. 2023;44(7):598–607.CrossRefPubMed van Dijk WB, Schuit E, van der Graaf R, Groenwold RHH, Laurijssen S, Casadei B, et al. Applicability of European Society of Cardiology guidelines according to gross national income. Eur Heart J. 2023;44(7):598–607.CrossRefPubMed
23.
go back to reference Stringer B, Lowton K, James N, Nyang’wa B. Capturing patient-reported and quality of life outcomes with use of shorter regimens for drug-resistant tuberculosis: mixed-methods substudy protocol, TB PRACTECAL-PRO. BMJ Open. 2021;11(9):e043954.CrossRefPubMedPubMedCentral Stringer B, Lowton K, James N, Nyang’wa B. Capturing patient-reported and quality of life outcomes with use of shorter regimens for drug-resistant tuberculosis: mixed-methods substudy protocol, TB PRACTECAL-PRO. BMJ Open. 2021;11(9):e043954.CrossRefPubMedPubMedCentral
24.
go back to reference Kim H, Novakovic U, Muntaner C, Hawkes MT. A critical assessment of the ideological underpinnings of current practice in global health and their historical origins. Glob Health Action. 2019;12(1):1651017.CrossRefPubMedPubMedCentral Kim H, Novakovic U, Muntaner C, Hawkes MT. A critical assessment of the ideological underpinnings of current practice in global health and their historical origins. Glob Health Action. 2019;12(1):1651017.CrossRefPubMedPubMedCentral
25.
26.
27.
go back to reference Kwete X, Tang K, Chen L, Ren R, Chen Q, Wu Z, et al. Decolonizing global health: what should be the target of this movement and where does it lead us? Global Health Res Policy. 2022;7(1):3.CrossRef Kwete X, Tang K, Chen L, Ren R, Chen Q, Wu Z, et al. Decolonizing global health: what should be the target of this movement and where does it lead us? Global Health Res Policy. 2022;7(1):3.CrossRef
37.
go back to reference Pratt B, de Vries J. Where is knowledge from the global South? An account of epistemic justice for a global bioethics. J Med Ethics. 2023;49(5):325–34.CrossRefPubMed Pratt B, de Vries J. Where is knowledge from the global South? An account of epistemic justice for a global bioethics. J Med Ethics. 2023;49(5):325–34.CrossRefPubMed
38.
go back to reference Robinson J, Kyobutungi C, Nyakoojo Z, Pai M. Editors as allies: our two-year experience at PLOS Global Public Health. PLOS Glob Public Health. 2023;3(11):e0002644.CrossRefPubMedPubMedCentral Robinson J, Kyobutungi C, Nyakoojo Z, Pai M. Editors as allies: our two-year experience at PLOS Global Public Health. PLOS Glob Public Health. 2023;3(11):e0002644.CrossRefPubMedPubMedCentral
40.
go back to reference Blackbourn HD, Migliori GB. Open access and the future of the IJTLD. Int J Tuberc Lung Dis. 2023;27(12):879.CrossRefPubMed Blackbourn HD, Migliori GB. Open access and the future of the IJTLD. Int J Tuberc Lung Dis. 2023;27(12):879.CrossRefPubMed
42.
go back to reference Kunnuji M, Shawar YR, Neill R, Manoj M, Shiffman J. Why “elevating country voice” is not decolonizing global health: a frame analysis of in-depth interviews. PLOS Glob Public Health. 2023;3(2):e0001365.CrossRefPubMedPubMedCentral Kunnuji M, Shawar YR, Neill R, Manoj M, Shiffman J. Why “elevating country voice” is not decolonizing global health: a frame analysis of in-depth interviews. PLOS Glob Public Health. 2023;3(2):e0001365.CrossRefPubMedPubMedCentral
47.
go back to reference Rees CA, Rajesh G, Manji HK, Shari C, Kisenge R, Keating EM, et al. Has authorship in the decolonizing global health movement been colonized? Ann Glob Health. 2023;89(1):42.CrossRefPubMedPubMedCentral Rees CA, Rajesh G, Manji HK, Shari C, Kisenge R, Keating EM, et al. Has authorship in the decolonizing global health movement been colonized? Ann Glob Health. 2023;89(1):42.CrossRefPubMedPubMedCentral
Metadata
Title
Revealing disparities in representation in knowledge generation and guideline development
Authors
Carlos P. B. Almeida
Afom T. Andom
Alain Casseus
Jacquelyn-My Do
Alain Gelin
Leonid Lecca
Maxo Luma
Michael Mazzi
Carole D. Mitnick
Jean Claude Mugunga
Melino Ndayizigiye
Natalie Nguyen
Meseret Tamirat
Girum Tefera
Sterman Toussaint
Marco Tovar
Christine Tzelios
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2024
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-024-11958-1